The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
To achieve our goal of healthy ageing for all women, we study the heritable nature of gynaecological cancers, how the first abnormal cells progress towards a cancer cell, and how we can intervene at any stage of this process.
We work together as a team of laboratory scientists and medical doctors to
improve treatment outcome through early detection, genetic and epigenetic screening;
Based on our research, we initiate clinical trials aimed to prevent or eliminate cancer. Our trials combine the best standard of care with novel therapies, including immunotherapy and intra-operative imaging. Our studies shape clinical best practices to directly benefit our patients.
By studying gynaecological cancer in the laboratory,
University Medical Center Groningen (UMCG)
Targeted Gynaecologic Oncology (TARGON)
P.O. Box 196
9700 AD Groningen